UBX - Unity Biotechnology, Inc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

UBX is currently covered by 4 analysts with average potential upside of $22.48 (180.62%) backed by 7 price targets and 19 ratings. Documented since 07-Sep-2018. Analyst's average stock valuation to be materialised ratio is 47.5% with an average time for price targets to be met of 48.5 days.

Most recent stock forecast was given by ANDREAS ARGYRIDES from WEDBUSH on 16-Mar-2023.

Highest price target for UBX is 63, Lowest price target is 2, average price target is 32.5.

Best performing analysts who are covering UBX - Unity Biotechnology, Inc:

Yigal Nochomovitz Salim Syed Elemer Piros Andreas Argyrides

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

35

$30.99 (772.82%)

7 days ago

1/2 (50%)

$16.1 (404.83%)

73

Buy

80

$75.99 (1895.01%)

50

7 months 8 days ago

2/5 (40%)

$21.42 (211.08%)

80

Buy

40

$35.99 (897.51%)

40

1 years 2 months 18 days ago

1/2 (50%)

$10.1 (57.49%)

1

Buy

50

1 years 4 months 13 days ago

2/4 (50%)

$42.28 (49.06%)

40

Show more analysts